X-101278103-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_001168474.2(TAF7L):c.523G>A(p.Val175Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000108 in 1,208,678 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000091 ( 0 hom. 6 hem. )
Consequence
TAF7L
NM_001168474.2 missense
NM_001168474.2 missense
Scores
4
9
4
Clinical Significance
Conservation
PhyloP100: 5.37
Genes affected
TAF7L (HGNC:11548): (TATA-box binding protein associated factor 7 like) This gene is similar to a mouse gene that encodes a TATA box binding protein-associated factor, and shows testis-specific expression. The encoded protein could be a spermatogenesis-specific component of the DNA-binding general transcription factor complex TFIID. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.913
BS2
High Hemizygotes in GnomAdExome4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF7L | NM_001168474.2 | c.523G>A | p.Val175Met | missense_variant | 8/13 | ENST00000356784.2 | NP_001161946.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF7L | ENST00000356784.2 | c.523G>A | p.Val175Met | missense_variant | 8/13 | 1 | NM_001168474.2 | ENSP00000349235 | A2 | |
TAF7L | ENST00000372907.7 | c.781G>A | p.Val261Met | missense_variant | 8/13 | 1 | ENSP00000361998 | P2 | ||
TAF7L | ENST00000324762.10 | c.523G>A | p.Val175Met | missense_variant | 7/11 | 2 | ENSP00000320283 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111781Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33955
GnomAD3 genomes
AF:
AC:
3
AN:
111781
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33955
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183097Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67585
GnomAD3 exomes
AF:
AC:
2
AN:
183097
Hom.:
AF XY:
AC XY:
1
AN XY:
67585
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000912 AC: 10AN: 1096897Hom.: 0 Cov.: 29 AF XY: 0.0000166 AC XY: 6AN XY: 362273
GnomAD4 exome
AF:
AC:
10
AN:
1096897
Hom.:
Cov.:
29
AF XY:
AC XY:
6
AN XY:
362273
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111781Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33955
GnomAD4 genome
AF:
AC:
3
AN:
111781
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33955
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | The c.781G>A (p.V261M) alteration is located in exon 8 (coding exon 8) of the TAF7L gene. This alteration results from a G to A substitution at nucleotide position 781, causing the valine (V) at amino acid position 261 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MutPred
Gain of ubiquitination at K266 (P = 0.0575);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at